BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hatipoğlu U, Stoller JK. α1-Antitrypsin Deficiency. Clin Chest Med 2016;37:487-504. [PMID: 27514595 DOI: 10.1016/j.ccm.2016.04.011] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Tejwani V, Stoller JK. The spectrum of clinical sequelae associated with alpha-1 antitrypsin deficiency. Ther Adv Chronic Dis 2021;12_suppl:2040622321995691. [PMID: 34408829 DOI: 10.1177/2040622321995691] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
2 Cazzola M, Calzetta L, Rogliani P, Matera MG. The Challenges of Precision Medicine in COPD. Mol Diagn Ther 2017;21:345-55. [PMID: 28247183 DOI: 10.1007/s40291-017-0266-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 8.0] [Reference Citation Analysis]
3 Stanley SE, Merck SJ, Armanios M. Telomerase and the Genetics of Emphysema Susceptibility. Implications for Pathogenesis Paradigms and Patient Care. Ann Am Thorac Soc 2016;13 Suppl 5:S447-51. [PMID: 28005428 DOI: 10.1513/AnnalsATS.201609-718AW] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 6.7] [Reference Citation Analysis]
4 Cazzola M, Rogliani P, Puxeddu E, Ora J, Matera MG. An overview of the current management of chronic obstructive pulmonary disease: can we go beyond the GOLD recommendations? Expert Review of Respiratory Medicine 2018;12:43-54. [DOI: 10.1080/17476348.2018.1398086] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
5 Boerema DJ, An B, Gandhi RP, Papineau R, Regnier E, Wilder A, Molitor A, Tang AP, Kee SM. Biochemical comparison of four commercially available human α1-proteinase inhibitors for treatment of α1-antitrypsin deficiency. Biologicals 2017;50:63-72. [PMID: 28882403 DOI: 10.1016/j.biologicals.2017.08.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
6 Yang Z, Gao R, Li B, Zhang D, Wang S, Wang R, Wang J, Wang J, Zhao J. Association between plasma immunoglobulin E and intracranial aneurysms. J Neurosurg Sci 2020;64:489-92. [PMID: 30514069 DOI: 10.23736/S0390-5616.18.04566-6] [Reference Citation Analysis]
7 Johnson EF, Tolkachjov SN, Gibson LE. Alpha-1 antitrypsin deficiency panniculitis: clinical and pathologic characteristics of 10 cases. Int J Dermatol 2018;57:952-8. [DOI: 10.1111/ijd.14012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
8 Vianello A, Guarnieri G, Braccioni F, Molena B, Lococo S, Achille A, Lionello F, Salviati L, Caminati M, Senna G. Correlation between α1-Antitrypsin Deficiency and SARS-CoV-2 Infection: Epidemiological Data and Pathogenetic Hypotheses. J Clin Med 2021;10:4493. [PMID: 34640510 DOI: 10.3390/jcm10194493] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Rigobello C, Baraldo S, Tinè M, Ferrarotti I, Corsico AG, Bazzan E, Turato G, Balestro E, Biondini D, Valle G, Saetta M, Cosio MG. Exome Sequencing Reveals Immune Genes as Susceptibility Modifiers in Individuals with α1-Antitrypsin Deficiency. Sci Rep 2019;9:13088. [PMID: 31511551 DOI: 10.1038/s41598-019-49409-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
10 Gilowska I, Kasper Ł, Bogacz K, Szczegielniak J, Szymasek T, Kasper M, Czerwinski M, Sładek K, Majorczyk E. Impact of Matrix Metalloproteinase 9 on COPD Development in Polish Patients: Genetic Polymorphism, Protein Level, and Their Relationship with Lung Function. Biomed Res Int 2018;2018:6417415. [PMID: 30643813 DOI: 10.1155/2018/6417415] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
11 Franciosi AN, Ralph J, O'Farrell NJ, Buckley C, Gulmann C, O'Kane M, Carroll TP, McElvaney NG. Alpha-1 antitrypsin deficiency-associated panniculitis. J Am Acad Dermatol 2021:S0190-9622(21)00232-2. [PMID: 33516773 DOI: 10.1016/j.jaad.2021.01.074] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
12 Lopes AP, Mineiro MA, Costa F, Gomes J, Santos C, Antunes C, Maia D, Melo R, Canotilho M, Magalhães E, Vicente I, Valente C, Gonçalves BG, Conde B, Guimarães C, Sousa C, Amado J, Brandão ME, Sucena M, Oliveira MJ, Seixas S, Teixeira V, Telo L. Portuguese consensus document for the management of alpha-1-antitrypsin deficiency. Pulmonology 2018;24 Suppl 1:1-21. [PMID: 30473034 DOI: 10.1016/j.pulmoe.2018.09.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
13 Takeda K, Kim SH, Joetham A, Petrache I, Gelfand EW. Therapeutic benefits of recombinant alpha1-antitrypsin IgG1 Fc-fusion protein in experimental emphysema. Respir Res 2021;22:207. [PMID: 34271910 DOI: 10.1186/s12931-021-01784-y] [Reference Citation Analysis]
14 Nesterova AP, Klimov EA, Zharkova M, Sozin S, Sobolev V, Ivanikova NV, Shkrob M, Yuryev A. Endocrine, nutritional, and metabolic diseases. Disease Pathways. Elsevier; 2020. pp. 121-218. [DOI: 10.1016/b978-0-12-817086-1.00004-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 da Costa CH, Noronha Filho AJ, Marques E Silva RMF, da Cruz TF, de Oliveira Monteiro V, Pio M, Rufino RL. Alpha 1-antitrypsin deficiency in patients with chronic obstructive pulmonary disease patients: is systematic screening necessary? BMC Res Notes 2019;12:10. [PMID: 30630519 DOI: 10.1186/s13104-018-4043-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
16 Gramegna A, Aliberti S, Confalonieri M, Corsico A, Richeldi L, Vancheri C, Blasi F. Alpha-1 antitrypsin deficiency as a common treatable mechanism in chronic respiratory disorders and for conditions different from pulmonary emphysema? A commentary on the new European Respiratory Society statement. Multidiscip Respir Med 2018;13:39. [PMID: 30338069 DOI: 10.1186/s40248-018-0153-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
17 Sondhi D, Stiles KM, De BP, Crystal RG. Genetic Modification of the Lung Directed Toward Treatment of Human Disease. Hum Gene Ther 2017;28:3-84. [PMID: 27927014 DOI: 10.1089/hum.2016.152] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]